Evaluation of different methods for the detection of minimal residual disease in blood and bone marrow of patients with primary breast cancer: importance for clinical use?

By Kasimir-Bauer S.  

Breast Cancer Research and Treatment, Vol. 69, Iss. 2, 2001-09 ,pp. : 123-132

Springer Publishing Company

Access to resources Recommend Favorite

Differential expression of minimal residual disease markers in peripheral blood and bone marrow samples from high-risk neuroblastoma patients

By                            

Oncology Letters, Vol. 10, Iss. 5, 2015-01 ,pp. : 3228-3232

Spandidos Publications

Access to resources Recommend Favorite

Minimal disease detection in peripheral blood and bone marrow from patients with non-metastatic neuroblastoma

By Yáñez Yania   Grau Elena   Oltra Silvestre   Cañete Adela   Martínez Francisco   Orellana Carmen   Noguera Rosa   Palanca Sarai   Castel Victoria  

Journal of Cancer Research and Clinical Oncology, Vol. 137, Iss. 8, 2011-08 ,pp. : 1263-1272

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Significance of Molecular Detection of Matrix metalloproteinase-1 in Bone Marrow and Peripheral Blood in Patients with Gastric Cancer

By Kosaka Yoshimasa   Mimori Koshi   Fukagawa Takeo   Ishikawa Kenji   Etoh Tsuyoshi   Katai Hitoshi   Sano Takeshi   Watanabe Masahiko   Sasako Mitsuru   Mori Masaki  

Annals of Surgical Oncology, Vol. 19, Iss. 3, 2012-07 ,pp. : 430-437

Springer Publishing Company

Access to resources Recommend Favorite

Eradication of Minimal Residual Disease with Alemtuzumab in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients: The Need for a Standard Method of Detection and the Potential Impact of Bone Marrow Clearance on Disease Outcome

By Montillo Marco   Schinkoethe Timo   Elter Thomas  

Cancer Investigation, Vol. 23, Iss. 6, 2005-09 ,pp. : 488-496

Informa Healthcare

Access to resources Recommend Favorite